Back to Agenda
Session 18: The FDA and Risk Management
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Premarketing Risk Assessment
- Postmarketing Risk Assessment
- Risk Evaluation and Mitigation Strategies
Have an account?